MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
Genetic variation in MYH9, encoding nonmuscle myosin IIA heavy chain, has been associated recently with increased risk for kidney disease. Previously, MYH9 missense mutations have been shown to cause the autosomal-dominant MYH9 (ADM9) spectrum, characterized by large platelets, leukocyte Döhle bodies, and, variably, sensorineural deafness, cataracts, and glomerulopathy. Genetic testing is indicated for familial and sporadic cases that fit this spectrum. By contrast, the MYH9 kidney risk variant is characterized by multiple intronic single nucleotide polymorphisms, but the causative variant has not been identified. Disease associations include human immunodeficiency virus-associated collapsing glomerulopathy, focal segmental glomerulosclerosis, hypertension-attributed end-stage kidney disease, and diabetes-attributed end-stage kidney disease. One plausible hypothesis is that the MYH9 kidney risk variant confers a fragile podocyte phenotype. In the case of hypertension-attributed kidney disease, it remains unclear if the hypertension is a contributing cause or a consequence of glomerular injury. The MYH9 kidney risk variant is strikingly more common among individuals of African descent, but only some will develop clinical kidney disease in their lifetime. Thus, it is likely that additional genes and/or environmental factors interact with the MYH9 kidney risk variant to trigger glomerular injury. A preliminary genetic risk stratification scheme, using two single nucleotide polymorphisms, may estimate lifetime risk for kidney disease. Nevertheless, at present, no role has been established for genetic testing as part of personalized medicine, but testing should be considered in clinical studies of glomerular diseases among populations of African descent. Such studies will address critical questions pertaining to MYH9-associated kidney disease, including mechanism, course, and response to therapy.
Kopp
Jeffrey B
JB
Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1268, USA. jbkopp@nih.gov
Winkler
Cheryl A
CA
Nelson
George W
GW
D016263:AIDS-Associated Nephropathy / Q000175:diagnosis / Q000235:genetics*; D000075944:Apolipoprotein L1; D001053:Apolipoproteins / Q000235:genetics; D044383:Black People / Q000235:genetics; D005820:Genetic Testing; D005838:Genotype; D005923:Glomerulosclerosis, Focal Segmental / Q000175:diagnosis / Q000235:genetics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000208:ethnology / Q000235:genetics*; D008075:Lipoproteins, HDL / Q000235:genetics; D020409:Molecular Motor Proteins / Q000235:genetics*; D018995:Myosin Heavy Chains / Q000235:genetics*; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D012306:Risk
C108666:APOL1 protein, human; D000075944:Apolipoprotein L1; D001053:Apolipoproteins; D008075:Lipoproteins, HDL; C103814:MYH9 protein, human; D020409:Molecular Motor Proteins; D018995:Myosin Heavy Chains
Clin Infect Dis. 2005 Jun 1;40(11):1559-85
15889353
Kidney Int. 2009 Apr;75(7):736-45
19177153
N Engl J Med. 1989 Sep 7;321(10):625-30
2770791
Nat Rev Mol Cell Biol. 2009 Nov;10(11):778-90
19851336
Am J Nephrol. 2009;29(6):626-32
19153477
Hum Mol Genet. 2010 May 1;19(9):1805-15
20124285
Science. 2009 Nov 27;326(5957):1208-12
19965462
J Natl Cancer Inst. 1993 Jun 2;85(11):892-7
8492317
Nephrol Dial Transplant. 2009 Nov;24(11):3366-71
19567477
Am J Physiol Renal Physiol. 2008 Oct;295(4):F959-70
18684887
Science. 2010 Aug 13;329(5993):841-5
20647424
J Am Soc Nephrol. 2005 Apr;16(4):1061-8
15716334
Am J Kidney Dis. 2003 Jan;41(1):95-104
12500226
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3681-6
16505385
J Am Soc Nephrol. 2006 Jan;17(1):66-76
16280470
Semin Nephrol. 2003 Mar;23(2):172-82
12704577
Nat Genet. 2008 Oct;40(10):1175-84
18794856
Nat Genet. 2008 Oct;40(10):1185-92
18794854
Medicine (Baltimore). 2003 May;82(3):203-15
12792306
Cancer Causes Control. 1996 Sep;7(5):544-52
8877053
Am J Kidney Dis. 2000 May;35(5):884-8
10793023